SG11202109389UA - Composition for intestinal barrier function improvement - Google Patents

Composition for intestinal barrier function improvement

Info

Publication number
SG11202109389UA
SG11202109389UA SG11202109389UA SG11202109389UA SG 11202109389U A SG11202109389U A SG 11202109389UA SG 11202109389U A SG11202109389U A SG 11202109389UA SG 11202109389U A SG11202109389U A SG 11202109389UA
Authority
SG
Singapore
Prior art keywords
composition
barrier function
intestinal barrier
function improvement
improvement
Prior art date
Application number
Inventor
Hideyuki Arie
Yuki Yagita
Yoshiko Ono
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of SG11202109389UA publication Critical patent/SG11202109389UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11202109389U 2019-03-26 2020-03-10 Composition for intestinal barrier function improvement SG11202109389UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019058508 2019-03-26
PCT/JP2020/010214 WO2020195774A1 (en) 2019-03-26 2020-03-10 Composition for intestinal barrier function improvement

Publications (1)

Publication Number Publication Date
SG11202109389UA true SG11202109389UA (en) 2021-10-28

Family

ID=72610117

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202109389U SG11202109389UA (en) 2019-03-26 2020-03-10 Composition for intestinal barrier function improvement

Country Status (6)

Country Link
JP (1) JPWO2020195774A1 (en)
CN (1) CN113613718A (en)
CA (1) CA3134887A1 (en)
SG (1) SG11202109389UA (en)
TW (1) TW202102210A (en)
WO (1) WO2020195774A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115505020B (en) * 2021-06-23 2023-09-12 沈阳药科大学 Ursolic acid saponin and its preparation method and use
CN115644451A (en) * 2022-09-30 2023-01-31 内蒙古伊利实业集团股份有限公司 Mineral composition and product and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170298090A1 (en) * 2016-04-08 2017-10-19 Kuling Therapeutics Modulators of ROR-gamma Receptors, Composition and Use Thereof

Also Published As

Publication number Publication date
TW202102210A (en) 2021-01-16
CN113613718A (en) 2021-11-05
CA3134887A1 (en) 2020-10-01
WO2020195774A1 (en) 2020-10-01
JPWO2020195774A1 (en) 2020-10-01

Similar Documents

Publication Publication Date Title
GB201911928D0 (en) Pharmaceutical compounds
GB201903287D0 (en) Composition
GB201911944D0 (en) Pharmaceutical compounds
GB201911517D0 (en) Pharmaceutical composition
IL291570A (en) Pharmaceutical compounds
GB201914910D0 (en) Pharmaceutical compounds
SG11202109389UA (en) Composition for intestinal barrier function improvement
SG11202005327YA (en) Composition for improving intestinal barrier function
SG11202005552UA (en) Composition for improving intestinal barrier function
SG11202110315SA (en) Pharmaceutical composition
EP4081251A4 (en) Pharmaceutical compositions
FI3908321T3 (en) Pharmaceutical composition
GB201917252D0 (en) Pharmaceutic compositions
GB201915932D0 (en) Pharmaceutical compounds
GB201915273D0 (en) Pharmaceutical compounds
GB201911694D0 (en) Composition
GB201907225D0 (en) Composition
GB201903340D0 (en) Composition
CA194487S (en) Barrier
SG11202005550QA (en) Composition for improving intestinal barrier function
ZA202006468B (en) Barrier
GB201914157D0 (en) Barrier
ZA202004873B (en) Barrier arrangement
GB201904877D0 (en) Barrier
IL285728A (en) Pharmaceutical composition